GAMMA Investing’s OptimizeRx OPRX Stock Holding History

GAMMA Investing’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.94K	Sell	352 -558	-61%	-$4.03K	﹤0.01%	3845
2026 Q2	$5.21K	Sell	910 -113	-11%	-$650	﹤0.01%	3447
2026 Q1	$6.42K	Buy	1,023 +458	+81%	+$4.25K	﹤0.01%	3268
2025 Q4	$6.93K	Buy	565 +9	+2%	+$147	﹤0.01%	3138
2025 Q3	$11.4K	Sell	556 -82	-13%	-$1.3K	﹤0.01%	2824
2025 Q2	$8.61K	Buy	638 +194	+44%	+$2.12K	﹤0.01%	2877
2025 Q1	$3.85K	Buy	+444	New	+$2.71K	﹤0.01%	3190
2024 Q4	–	Sell	-266	Closed	-$2.05K	–	3812
2024 Q3	$2.05K	Buy	266 +265	+26,500%	+$2.35K	﹤0.01%	3066
2024 Q2	$10	Buy	+1	New	+$11	﹤0.01%	3441

Other funds holding OPRX

GWM

GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's OPRX Position: Q3 2026 in Review

GAMMA Investing reduced its OptimizeRx (OPRX) stake by 61% in Q3 2026, selling an estimated $4.03K and leaving 352 shares worth $2.94K. The position accounts for ﹤0.01% of the portfolio, ranked #3845.

GAMMA Investing first reported a position in OPRX in Q2 2024 and has held it in 9 quarters since. The position peaked at $11.4K in Q3 2025. 4 funds tracked by Wall St. Rank hold OPRX as of Q3 2026.

GAMMA Investing held 352 shares of OptimizeRx worth $2.94K as of Q3 2026.
GAMMA Investing sold 558 OptimizeRx shares in Q3 2026, an estimated $4.03K.
OptimizeRx made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3845 holding.
GAMMA Investing first reported a position in OptimizeRx in Q2 2024 and has held it in 9 quarters since.
GAMMA Investing's OptimizeRx position peaked at $11.4K in Q3 2025.
4 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.